×
FOLLOW THE WEEK ON FACEBOOK
October 18, 2017
Dan Kitwood/Getty Images

The Food and Drug Administration on Wednesday approved a one-time treatment for lymphoma in adults, only the second time a gene therapy for blood cancer has been given the okay in the United States.

This is the first gene therapy approved for adults, and it involves removing a patient's T cells, reprogramming them to find and kill cancer cells, then putting the cells back into the patient, The Associated Press reports. The treatment uses the same technology as a gene therapy recently approved in the U.S. for childhood leukemia, and will cost $373,000 per patient, its manufacturer said. Catherine Garcia

July 12, 2017
Dan Kitwood/Getty Images

A new cancer treatment endorsed Wednesday by the Federal Drug Administration's Oncologic Drugs Advisory Committee is being described by one panel member as "the most exciting thing I've seen in my lifetime."

CAR T-cell therapy, made by Novartis, retrains a patient's immune cells so they target and attack cancer; the cells are removed from the body, sent to Novartis' plant so they can be genetically modified, and then shipped back to the patient for infusion. Novartis is seeking approval for use in children and young adults with leukemia who have relapsed despite undergoing chemotherapy. Stephen Grupp, the oncologist who led Novartis' trial, said most of the patients experienced cytokine release syndrome, which results in fever and flulike symptoms, and some had seizures and delirium.

If the FDA approves CAR T-cell therapy, which could happen by the end of September, it would be the first gene therapy cleared for use in the United States. Thomas Whitehead's daughter, Emily, was the first child to go through the treatment, at age six. She had leukemia and was close to death, he said, and while the CAR T-cell therapy nearly killed her, she survived and no longer has cancer, The Washington Post reports. He spoke in front of the Oncologic Drugs Advisory Committee on Wednesday and told them, "If you want to see what a cure looks like for relapsed ALL [acute lymphoblastic leukemia], she's standing right beside me." Catherine Garcia